0.21 ML risperidone 357 MG/ML Prefilled Syringe
- RxCUI
- 2636051
- RxNorm name
- 0.21 ML risperidone 357 MG/ML Prefilled Syringe
- Display name
- 0.21 ML risperidone 357 MG/ML Prefilled Syringe
- Full name
- 0.21 ML risperidone 357 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UZEDY | RISPERIDONE | Teva Pharmaceuticals USA, Inc. | 734eb776-4be0-4808-834b-0d8b0f9e021e | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 2636051 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 734eb776-4be0-4808-834b-0d8b0f9e021e | 0.21 ML risperidone 357 MG/ML Prefilled Syringe | SCD | 7 | These highlights do not include all the information needed to use UZEDY ® safely and effectively. See full prescribing information for UZEDY. UZEDY (risperidone) extended-release injectable suspension, for subcutaneous use Initial U.S. Approval: 1993 | 20251009 |
| 734eb776-4be0-4808-834b-0d8b0f9e021e | risperidone 75 MG per 0.21 ML Prefilled Syringe | SY | 7 | These highlights do not include all the information needed to use UZEDY ® safely and effectively. See full prescribing information for UZEDY. UZEDY (risperidone) extended-release injectable suspension, for subcutaneous use Initial U.S. Approval: 1993 | 20251009 |
| 734eb776-4be0-4808-834b-0d8b0f9e021e | risperiDONE 75 MG in 0.21 ML Prefilled Syringe | PSN | 7 | These highlights do not include all the information needed to use UZEDY ® safely and effectively. See full prescribing information for UZEDY. UZEDY (risperidone) extended-release injectable suspension, for subcutaneous use Initial U.S. Approval: 1993 | 20251009 |